Eldesoqui, M.; Eldken, Z.H.; Mostafa, S.A.; Al-Serwi, R.H.; El-Sherbiny, M.; Elsherbiny, N.; Mohammedsaleh, Z.M.; Sakr, N.H.
Exercise Augments the Effect of SGLT2 Inhibitor Dapagliflozin on Experimentally Induced Diabetic Cardiomyopathy, Possible Underlying Mechanisms. Metabolites 2022, 12, 635.
https://doi.org/10.3390/metabo12070635
AMA Style
Eldesoqui M, Eldken ZH, Mostafa SA, Al-Serwi RH, El-Sherbiny M, Elsherbiny N, Mohammedsaleh ZM, Sakr NH.
Exercise Augments the Effect of SGLT2 Inhibitor Dapagliflozin on Experimentally Induced Diabetic Cardiomyopathy, Possible Underlying Mechanisms. Metabolites. 2022; 12(7):635.
https://doi.org/10.3390/metabo12070635
Chicago/Turabian Style
Eldesoqui, Mamdouh, Zienab Helmy Eldken, Sally Abdallah Mostafa, Rasha Hamed Al-Serwi, Mohamed El-Sherbiny, Nehal Elsherbiny, Zuhair M. Mohammedsaleh, and Noha Hammad Sakr.
2022. "Exercise Augments the Effect of SGLT2 Inhibitor Dapagliflozin on Experimentally Induced Diabetic Cardiomyopathy, Possible Underlying Mechanisms" Metabolites 12, no. 7: 635.
https://doi.org/10.3390/metabo12070635
APA Style
Eldesoqui, M., Eldken, Z. H., Mostafa, S. A., Al-Serwi, R. H., El-Sherbiny, M., Elsherbiny, N., Mohammedsaleh, Z. M., & Sakr, N. H.
(2022). Exercise Augments the Effect of SGLT2 Inhibitor Dapagliflozin on Experimentally Induced Diabetic Cardiomyopathy, Possible Underlying Mechanisms. Metabolites, 12(7), 635.
https://doi.org/10.3390/metabo12070635
